Study: Daily aspirin may guard against melanoma

06/29/2011 | MSNBC

People who took an aspirin daily for at least five years were almost 50% less likely to get melanoma than people who did not take aspirin, a review of medical records found. "Our data at least support the hypothesis that long-term steady aspirin use has an effect," said Harvard professor of dermatology and study co-author Dr. Robert Stern. The data on other nonsteroidal anti-inflammatory drugs, such as ibuprofen and naproxen, were not as strong, and the researchers found no link between cholesterol-lowering statins and reduced melanoma risk.

View Full Article in:

MSNBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA